期刊
MOLECULAR AND CELLULAR ENDOCRINOLOGY
卷 489, 期 -, 页码 119-125出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.mce.2018.10.014
关键词
HSD17B13; NAFLD; Lipid droplets; Genome-wide association study; Proteomics
资金
- National Natural Science Foundation - Foundation of Shenzhen Basic Research Project [81500538/81500619/81870405]
- Natural Science Foundation of Shenzhen University [JCYJ20170818144501119]
- Robert A. Welch Foundation [2017093]
- [E - 0004]
17 beta-Hydroxysteroid dehydrogenases (HSD17Bs) comprise a large family of 15 members that are mainly involved in sex hormone metabolism. Some HSD17Bs enzymes also play key roles in cholesterol and fatty acid metabolism. Recent study showed that hydroxysteroid 17 beta-dehydrogenase 13 (HSD17B13), an enzyme with unknown biological function, is a novel liver-specific lipid droplet (LD)-associated protein in mouse and humans. HSD17B13 expression is markedly upregulated in patients and mice with non-alcoholic fatty liver disease (NAFLD). Hepatic overexpression of HSD17B13 promotes lipid accumulation in the liver. In this review, we summarize recent progress regarding the role of HSD17B13 in the regulation of hepatic lipid homeostasis and discuss genetic, genomic and proteomic evidence supporting the pathogenic role of HSD17B13 in NAFLD. We also emphasize its potential as a biomarker of advanced liver disease, such as non-alcoholic steatohepatitis (NASH) and liver cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据